Greenland Mines Ltd. Common Stock (NASDAQ:GRML – Get Free Report) released its quarterly earnings results on Monday. The company reported ($0.03) EPS for the quarter, Zacks reports.
Greenland Mines Ltd. Common Stock Trading Down 2.0%
Shares of NASDAQ:GRML opened at $0.20 on Tuesday. The firm has a 50 day moving average of $0.23 and a 200-day moving average of $0.35. The stock has a market capitalization of $27.52 million, a PE ratio of -0.62 and a beta of 7.13. Greenland Mines Ltd. Common Stock has a 12 month low of $0.16 and a 12 month high of $0.95.
Insider Activity at Greenland Mines Ltd. Common Stock
In other news, Director Jason David Sawyer acquired 240,000 shares of the firm’s stock in a transaction that occurred on Wednesday, July 22nd. The shares were acquired at an average cost of $0.23 per share, with a total value of $55,200.00. Following the completion of the purchase, the director directly owned 240,000 shares of the company’s stock, valued at $55,200. The trade was a ∞ increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Riad Hussein El-Dada sold 175,000 shares of the business’s stock in a transaction that occurred on Thursday, June 25th. The shares were sold at an average price of $0.23, for a total transaction of $40,250.00. Following the transaction, the director owned 175,000 shares of the company’s stock, valued at approximately $40,250. This represents a 50.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 11.30% of the company’s stock.
Institutional Investors Weigh In On Greenland Mines Ltd. Common Stock
Wall Street Analysts Forecast Growth
A number of research analysts have issued reports on GRML shares. Weiss Ratings lowered shares of Greenland Mines Ltd. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Tuesday, August 11th. Wall Street Zen upgraded Greenland Mines Ltd. Common Stock to a “sell” rating in a research note on Saturday, May 2nd. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has a consensus rating of “Sell”.
Check Out Our Latest Stock Analysis on Greenland Mines Ltd. Common Stock
About Greenland Mines Ltd. Common Stock
Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases – cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.
Featured Stories
- Five stocks we like better than Greenland Mines Ltd. Common Stock
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Receive News & Ratings for Greenland Mines Ltd. Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Greenland Mines Ltd. Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.
